Emcure Pharmaceuticals (EMCURE) Share Price Rises 2.46% as Stock Gains Today
- September 4, 2026
- Posted by: Kunal Singla
- Category: News
Emcure Pharmaceuticals Share Price moved higher today, with Emcure Pharmaceuticals Share Price last traded at Rs 2,396.6, up 2.46% from the previous close of Rs 2,339. The company’s market capitalisation stood at Rs 44,378.06 crore, placing Emcure Pharmaceuticals Share Price firmly in the healthcare and pharmaceuticals discussion for the Indian market. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. In the absence of a verified reason, the move is best read through today’s price action, the company’s valuation profile and the sector benchmark. Emcure Pharmaceuticals Share Price is therefore relevant not only as a share price rise, but also as a live reference point for investors tracking stock news, price action and fundamental analysis on Univest.
As of 18 November 2026 at 11:52:52 AM IST, Emcure Pharmaceuticals Share Price had already matched the day’s high of Rs 2,396.6 after opening at Rs 2,350 and touching a low of Rs 2,344. The move is notable because the stock is trading above the previous close, but the session context remains purely numerical rather than catalyst-led. For readers following Emcure Pharmaceuticals Share Price Today, the key question is how today’s rise fits with the company’s valuation, profitability ratios and healthcare peer set.
Emcure Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,396.6 |
| Previous Close | Rs 2,339 |
| Today's Move | Rs 57.6 (+2.46%) |
| Open | Rs 2,350 |
| High | Rs 2,396.6 |
| Low | Rs 2,344 |
| Market Capitalisation | Rs 44,378.06 crore |
| Market Cap Category | Large Cap |
Emcure Pharmaceuticals Ltd. (EMCURE) rose to Rs 2,396.6 from the previous close of Rs 2,339, a move of Rs 57.6 or 2.46%. The stock opened at Rs 2,350, reached a high of Rs 2,396.6, recorded a low of Rs 2,344.
Emcure Pharmaceuticals Share Price rose 2.46% today, adding Rs 57.6 from the previous close and reaching Rs 2,396.6. The stock opened at Rs 2,350, moved between Rs 2,344 and Rs 2,396.6, and is trading at the day’s high at the time of writing. That sequence shows a clean price rise within the session, with Emcure Pharmaceuticals Share Price holding above the prior close through the current market update.
The move places Emcure Pharmaceuticals Share Price in the day’s top-gainer conversation without adding any unverified narrative around why it is rising today. What matters here is the exact price action: a higher current price, a positive day change and a high that currently matches the last traded level. For anyone tracking Emcure Pharmaceuticals Share Price Live, this is a straightforward intraday gain backed by Univest figures. The next layer is whether the company’s fundamentals and valuation support continued attention from a stock analysis perspective.
Emcure Pharmaceuticals Ltd. (EMCURE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 44,378.06 crore |
| P/E Ratio | 40.58x |
| P/B Ratio | 8.3x |
| ROE | 20.09% |
| ROCE | 25.25% |
| EPS | Rs 57.64 |
| Book Value Per Share | Rs 281.69 |
| Dividend Yield | 0.15% |
Emcure Pharmaceuticals Ltd. (EMCURE) fundamental metrics show P/E 40.58x, P/B 8.3x, ROE 20.09%, ROCE 25.25%. These figures provide context only and are not a buy or sell signal.
Emcure Pharmaceuticals Ltd. has a market capitalisation of Rs 44,378.06 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 40.58x, P/B at 8.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.09% and ROCE of 25.25%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 57.64, book value per share of Rs 281.69, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.01x, median ROE of 11.33%, median ROCE of 13.1%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 40.58x |
| Benchmark Median P/E | 31.01x |
| Benchmark Average P/E | 58.7x |
| Benchmark P/E Range | 2.75x to 1,425.63x |
| Company P/B Ratio | 8.3x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 20.09% |
| Benchmark Median ROE | 11.33% |
| Company ROCE | 25.25% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 44,378.06 crore |
| Benchmark Median Market Cap | Rs 791.38 crore |
Emcure Pharmaceuticals Ltd. (EMCURE) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Emcure Pharmaceuticals Ltd. (EMCURE) has a P/E ratio of 40.58x, which is above the benchmark median of 31.01x, a difference of +30.86%. On its own, the P/E gap is a valuation reference point, not a trading call.
Emcure Pharmaceuticals Ltd. (EMCURE) has a ROE of 20.09%, which is above the benchmark median of 11.33%, a difference of +77.32%. Emcure Pharmaceuticals Ltd. (EMCURE) has a ROCE of 25.25%, which is above the benchmark median of 13.1%, a difference of +92.75%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,47,943.84 | 40.92 | 5.03 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,94,962.14 | 87.74 | 16.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,78,390.62 | 83.65 | 9.67 | 26.76 | 19.27 |
| Laurus Labs Ltd. | LAURUSLABS | 1,19,789.92 | 94.36 | 20.86 | 18.31 | 18.2 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,603.21 | 28.7 | 4.31 | 19.69 | 21.39 |
Emcure Pharmaceuticals Ltd. (EMCURE) has a P/E ratio of 40.58x compared with the displayed peer median of 83.65x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 20.09% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 25.25% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Emcure Pharmaceuticals Ltd. (EMCURE) has a market capitalisation of Rs 44,378.06 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Emcure Pharmaceuticals
- Emcure Pharmaceuticals Share Price is trading higher today, with a verified gain of 2.46% and a last traded level of Rs 2,396.6.
- The price move is supported by a market capitalisation of Rs 44,378.06 crore, which keeps Emcure Pharmaceuticals Share Price in a meaningful healthcare market-cap bracket.
- Emcure Pharmaceuticals Fundamental Analysis shows P/E, P/B, ROE and ROCE values that can be compared directly with the same-industry benchmark.
- Emcure Pharmaceuticals Share Price Today is above the industry median on both earnings and book-value valuation, while returns on equity and capital employed are also above benchmark medians.
- Emcure Pharmaceuticals Stock Analysis gains context from peers such as Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd. and Zydus Lifesciences Ltd.
About Emcure Pharmaceuticals
Emcure Pharmaceuticals Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The company’s stock market identity today is shaped by its size, profitability ratios and valuation profile rather than by a one-line market move alone. Emcure Pharmaceuticals Share Price reflects a business that belongs to a large and competitive pharmaceutical universe, where return ratios and book-value discipline matter alongside market capitalisation.
For readers following Emcure Pharmaceuticals Share News, the company belongs to a sector where company financials, company overview and market update reading are essential. the latest Univest figures show EPS of Rs 57.64, book value of Rs 281.69 and dividend yield of 0.15%, which together offer a basic earnings and valuation framework. Emcure Pharmaceuticals Share Price therefore sits in a part of the market where fundamentals, sector analysis and peer comparison are central to how the stock is interpreted. Univest tracks such companies because the combination of price action and financial analysis often helps readers understand why a stock is being discussed today.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Emcure Pharmaceuticals Share Price rising today?
Ans. Emcure Pharmaceuticals Share Price is up 2.46% today to Rs 2,396.6. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The move is therefore best read through price action and valuation.
What is Emcure Pharmaceuticals Share Price today?
Ans. Emcure Pharmaceuticals Share Price is last traded at Rs 2,396.6, up Rs 57.6 from the previous close of Rs 2,339. The stock also touched a high of Rs 2,396.6 during the session.
What is Emcure Pharmaceuticals market cap?
Ans. Emcure Pharmaceuticals Share Price corresponds to a market capitalisation of Rs 44,378.06 crore. That makes the company materially larger than the industry median market cap of Rs 791.38 crore in the same-industry benchmark.
How does Emcure Pharmaceuticals compare with sector peers?
Ans. Emcure Pharmaceuticals Share Price compares closely with Sun Pharmaceutical Industries Ltd. on P/E, while its ROE and ROCE are stronger than several peers. It sits below Divi’s Laboratories Ltd. and Torrent Pharmaceuticals Ltd. on market cap.
Is Emcure Pharmaceuticals Share Price expensive versus the industry?
Ans. Emcure Pharmaceuticals Share Price trades above the industry median P/E of 31.01 and P/B of 2.88. That places it at a premium to the benchmark median, although its returns are also above the same-industry medians.
What sector does Emcure Pharmaceuticals belong to?
Ans. Emcure Pharmaceuticals Share Price belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The same-industry benchmark covers 199 companies, which helps place the stock’s valuation and return ratios in context.
Track Emcure Pharmaceuticals Share Price on Univest
Use Emcure Pharmaceuticals Ltd. (EMCURE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Emcure Pharmaceuticals Share Price on Univest for live price updates, valuation ratios, sector context and key market insights. The platform also helps readers follow Emcure Pharmaceuticals Share Price Today alongside market capitalisation, earnings metrics, 52-week levels and broader stock performance. For those comparing Emcure Pharmaceuticals Share Price with healthcare peers, Univest keeps the numbers in one place and makes the analysis easier to read.
Emcure Pharmaceuticals Share Price is best monitored through a mix of price action and fundamentals. Univest brings both together, so users can keep an eye on the current share price, market cap and sector benchmark without losing the company context. That is especially useful when Emcure Pharmaceuticals Stock News is driven by a same-day price rise and the catalyst is not established.